向铁亡:对于脏疾病来说,这是一个新的治疗机会
Zhiyong Long1, Yanfang Luo2, Min Yu1
1Department of Physical Medicine and Rehabilitation, The Affiliated Panyu Central Hospital of Guangzhou Medical University, Guangzhou, China.
Frontiers in immunology
|July 18, 2024
概括
铁,一种依赖于铁的细胞死亡,与脏疾病有关. 了解其机制为急性损伤和慢性病等疾病提供了新的治疗途径.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 铁亡是一种受调节的细胞死亡途径,取决于铁的积累和脂质过氧化.
- 它涉及氧化还原平衡,铁代谢和细胞代谢途径之间的复杂相互作用.
研究的目的:
- 审查铁灭的概念和机制.
- 要总结关于铁死在脏疾病中的作用的最新研究.
- 突出潜在的治疗策略,针对脏疾病中的ferroptosis.
主要方法:
- 对铁亡机制的文献综述 (GSH-GPX4,FSP1-CoQ1,DHODH-CoQ10,GCH1-BH4,MBOAT1/2通道). 它们是什么?
- 分析铁灭菌对脏器官发育,衰老,免疫力和癌症的参与.
- 在代谢,活性氧和铁生物学框架内综合研究.
主要成果:
- 铁亡机制是复杂的,涉及多个信号通路.
- 铁亡与各种脏疾病的发病有关,包括AKI,CKD,DN和细胞癌.
- 确定了与脏疾病相关的铁亡的关键调节因素和开放问题.
结论:
- 铁衰是病发展和进展中的关键生物过程.
- 对铁灭菌机制的进一步研究可能会导致脏疾病的新治疗方法.
- 向铁亡有望预防和治疗临床病.
相关概念视频
Necrosis
4.4K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.4K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K


